Rovazolac |
| Katalog-Nr.GC32054 |
Rovazolac ist ein Modulator des Leber-X-Rezeptors (LXR), der aus dem Patent WO2013130892A1 extrahiert wurde.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1454288-88-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
Rovazolac is an anti-inflammatory drug candidate[1].
[1]. Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1
Average Rating: 5 (Based on Reviews and 27 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *